China, which gifted the world with a deadly virus outbreak this year is now racing against time to somehow sell its unreliable and unsafe vaccine candidate across the globe, particularly to developing countries with whom the paper dragon has lost much favour due to its strategic decision of letting the virus causing Covid-19 spread its tentacles uncontrollably all around. Now, however, China is looking to trap developing countries with its vaccine diplomacy. However, CoronaVac, also known as Sinovac, which China hopes to sell across the world, has failed miserably in Brazil in the clinical trials which were concluded in the Latin country recently.
Achieving only about 50 per cent efficacy, the Chinese dream of conquering the world with its vaccine diplomacy is bound to suffer a major blow. If achieving a shameful efficacy of 50 per cent, while looking to compete with American and other leading pharmaceutical companies around the world wasn’t already enough, China has now resorted to what it does best – fudging data. In order to publish false and fictitious data of CoronaVac’s efficacy, Chinese company Sinovac Biotech Ltd. has now asked its Brazilian partners to withhold release of complete data.
This has been done for the single purpose of curating international data from all of Sinovac’s trial sites around the world and consequently releasing data which is bloated and miles away from the vaccine’s actual ability to trigger an immune response against Coronavirus. It must be remembered that the 50% efficacy rate is a minimum standard set by US regulators for emergency authorization of Covid vaccines. For a country like China, however, which has engaged itself in a prestige battle against pharmaceutical majors like Moderna Inc. and Pfizer Inc., a 50 per cent efficacy rate of its vaccine is a shameful loss of face.
In order to save itself the embarrassment, Sinovac Biotech, at the behest of the CCP, will work overtime for the next few days to curate fake data of its vaccine candidate. Predictably, the company will then announce the fabricated results with much pomp and grandeur. Already, however, people across the world have seen through China’s plans. In Brazil itself, over 50 per cent of the people have comprehensively rejected the vaccine, with their President itself calling the Chinese origin of the vaccine into question.
Read more: Chinese reject Chinese vaccine: 90 per cent of Chinese workers say NO to China’s fake Covid vaccine
China is a master at fabricating numbers and data. Whether it be the economy, Covid-19 cases or now, vaccine efficacy, the paper dragon has historically fudged and continues to falsify numbers and data. By fudging data of its vaccine candidates, however, China is readily playing with human lives. As if killing millions of people across the globe wasn’t already enough, China is now seeking to cause harm to human civilization by inoculating people in poorer countries with highly unsafe vaccines.
Why would China request its partners in Brazil to stop data regarding vaccine efficacy from being published, if not for some desperate last-minute cosmeticizing of CoronaVac’s efficacy levels? Already, Sinovac Biotech has asked Brazil to withhold the release of data three times in one month. Rest assured, the time it has asked for will be used to fabricate data in order to sell its vaccine around the world with a sense of pride. The democratic world must realise the threat to the health and safety of people, and take immediate steps to ensure that China’s vaccine is not sold to any country.